Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.

Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.
复制标题

DOI:
10.1021/ol101482h
复制
发表时间:
2010-10-15
期刊:
影响因子:
5.2
通讯作者:
Seley-Radtke KL
Seley-Radtke KL
中科院分区:
化学1区
文献类型:
--
作者:
Wauchope OR;Tomney MJ;Pepper JL;Korba BE;Seley-Radtke KL

文献摘要

参考文献

被引文献

相似文献

三环核苷和2′-修饰核苷在许多治疗领域都有很好的生物活性。特别是,核苷C-2′位的双取代产生了显著的抗丙型肝炎病毒(HCV)活性。结合我们实验室开发的三环核苷已显示出抑制RNA依赖性RNA聚合酶NS 5 B的观察结果,设计了一系列2′-修饰的三环核苷。详细的合成,结构表征和初步的生物学结果的报告。
Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2′-modified nucleosides. In particular, di-substitution at the C-2′ position of nucleosides has resulted in significant activity against the Hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2′-modified tricyclic nucleosides. Details of the synthesis, structural characterization and preliminary biological results are reported.
DOI: 10.1074/jbc.m106880200
发表时间: 2002-01-18
影响因子: 4.8
作者:
Qin, WP;Luo, H;Murakami, S
通讯作者: Murakami, S
DOI: 10.1021/jo00939a008
发表时间: 1974-01-01
影响因子: 3.6
作者:
NIEDBALLA, U;VORBRUGGEN, H
通讯作者: VORBRUGGEN, H
DOI: 10.1021/jm0502788
发表时间: 2005-08-25
影响因子: 7.3
作者:
Clark, JL;Hollecker, L;Pankiewiez, KW
通讯作者: Pankiewiez, KW
DOI: 10.1016/j.tet.2008.09.011
发表时间: 2008-11-24
期刊: Tetrahedron
影响因子: 2.1
作者:
Zhang Z;Wauchope OR;Seley-Radtke KL
通讯作者: Seley-Radtke KL
DOI: 10.1021/jo0255476
发表时间: 2002-05-17
影响因子: 3.6
作者:
Seley, KL;Zhang, L;Quirk, S
通讯作者: Quirk, S